EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 181 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,256,866 | -1.0% | 2,428,490 | +114.1% | 0.03% | 0.0% |
Q2 2023 | $8,337,987 | -14.7% | 1,134,420 | +20.2% | 0.03% | -18.4% |
Q1 2023 | $9,776,318 | -1.1% | 943,660 | +12.7% | 0.04% | 0.0% |
Q4 2022 | $9,889,222 | +33.7% | 837,360 | +137.5% | 0.04% | +18.8% |
Q3 2022 | $7,399,000 | -12.4% | 352,500 | +29.6% | 0.03% | -5.9% |
Q2 2022 | $8,445,000 | -15.4% | 272,060 | +11.8% | 0.03% | +6.2% |
Q1 2022 | $9,988,000 | -0.2% | 243,260 | +5.7% | 0.03% | +3.2% |
Q4 2021 | $10,008,000 | +32.2% | 230,230 | +52.2% | 0.03% | +29.2% |
Q3 2021 | $7,572,000 | +256.8% | 151,230 | +322.5% | 0.02% | +166.7% |
Q4 2018 | $2,122,000 | -32.2% | 35,794 | -24.7% | 0.01% | -18.2% |
Q3 2018 | $3,130,000 | +76.1% | 47,548 | +35.1% | 0.01% | +57.1% |
Q2 2018 | $1,777,000 | +73.0% | 35,192 | +80.4% | 0.01% | +75.0% |
Q1 2018 | $1,027,000 | +13.4% | 19,507 | 0.0% | 0.00% | +33.3% |
Q4 2017 | $906,000 | – | 19,507 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |